Cmp Pharma Introduces Liqrev, The Ready-Made Us Fda-Approved Liquid Suspension Of Sildenafil

Cmp Pharma Introduces Liqrev, The Ready-Made Us Fda-Approved Liquid Suspension Of Sildenafil

Cmp Pharma, Inc. Announced That Liqrev (Sildenafil) Oral Suspension, 10 Mg/Ml, The First And Only Fda-Approved Ready-Made Oral Liquid Of Sildenafil, Is Now Available.Liqrev Is A Liquid Oral Suspension Of Sildenafil Formulated For Patients With Dysphagia Or Difficulty Swallowing Tablets. Liqrev Is Indicated For The Treatment Of Pulmonary Arterial Hypertension To Improve Exercise Ability And Delay Clinical Worsening.Fda-Approved Liqrev Addresses The Inconsistencies That Come From Unapproved Crushed Or Compounded Tablets And Removes The Need For Complex Preparation Of Powder Formulations. Liqrev Has A Strawberry Flavor And Is Available In 122 Ml Bottles With A 24-Month Shelf Life.

Optimize Your trial insights with Clival Database.

Are you exhausted from the uncertainty of trial insights pricing? Clival Database ensures the clarity in the midst of the global scenario for clinical trials to you.

Clival Database is one of the best databases that offers an outstanding number of clinical trial data in terms of 50,000+ molecules and from primary regulatory markets as well as new entrants like Indian and Chinese markets.

With Clival, you get accurate positioning of historical sales data, patent database, company profiling, safety & efficacy, and prediction of launch of new innovative molecules helping you to align your research and driving down the cost.

To add value, we further break down our analytics for you so that improving your operational effectiveness; optimizing your clinical trials; and offering you accurate and high-quality data at lowest possible prices becomes possible.

Elevate your trial success rate with the cutting-edge insights from Clival database.

Check it out today and make more informed sourcing decisions! Learn More!